- Home
- BWAY vs PCF Comparison
BWAY vs PCF Comparison
Compare BWAY & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- PCF
- Stock Information
- Founded
- BWAY 2003
- PCF 1987
- Country
- BWAY Israel
- PCF United States
- Employees
- BWAY N/A
- PCF N/A
- Industry
- BWAY Medical/Dental Instruments
- PCF Trusts Except Educational Religious and Charitable
- Sector
- BWAY Health Care
- PCF Finance
- Exchange
- BWAY Nasdaq
- PCF Nasdaq
- Market Cap
- BWAY 177.4M
- PCF 196.9M
- IPO Year
- BWAY 2019
- PCF N/A
- Fundamental
- Price
- BWAY $9.56
- PCF $6.55
- Analyst Decision
- BWAY Strong Buy
- PCF
- Analyst Count
- BWAY 3
- PCF 0
- Target Price
- BWAY $13.17
- PCF N/A
- AVG Volume (30 Days)
- BWAY 46.4K
- PCF 74.8K
- Earning Date
- BWAY 11-12-2024
- PCF 01-01-0001
- Dividend Yield
- BWAY N/A
- PCF 10.90%
- EPS Growth
- BWAY N/A
- PCF N/A
- EPS
- BWAY 0.04
- PCF N/A
- Revenue
- BWAY $38,631,000.00
- PCF N/A
- Revenue This Year
- BWAY $378.91
- PCF N/A
- Revenue Next Year
- BWAY $20.27
- PCF N/A
- P/E Ratio
- BWAY $123.49
- PCF N/A
- Revenue Growth
- BWAY 34.19
- PCF N/A
- 52 Week Low
- BWAY $4.61
- PCF $5.71
- 52 Week High
- BWAY $10.98
- PCF $6.96
- Technical
- Relative Strength Index (RSI)
- BWAY 50.25
- PCF 46.70
- Support Level
- BWAY $8.90
- PCF $6.41
- Resistance Level
- BWAY $9.49
- PCF $6.52
- Average True Range (ATR)
- BWAY 0.32
- PCF 0.11
- MACD
- BWAY 0.04
- PCF 0.01
- Stochastic Oscillator
- BWAY 79.64
- PCF 62.50
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About PCF High Income Securities Fund
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective primarily by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.